A dry flowable formulation of Clonostachys rosea with fungicidal activity against Sclerotinia sclerotiorum was prepared by spray drying. The formulation was optimized by a four-factor, three-level orthogonal experiment to screen inert ingredients and spray-drying conditions. The optimal dry flowable formulation of C. rosea included 30% C. rosea (ratio of conidia powder and its fermentation broth is 1:3), 3% Morwet EFW, 4% k12, 10% Morwet D425, 9% sodium salt of polynaphthalene sulphonic acid (NNO), 5% croscarmellose sodium, 5% (NH 4) 2 SO 4 , 0.5% carboxymethyl cellulose sodium (CMC-Na), 1% oxalic acid and palygorskite (carrier) up to 100%. The formulation exhibited good physical characteristics, such as high dispersibility, viability and a long shelf life. Plate antagonism tests and pot trials indicated that the dry flowable formulation was very effective against S. sclerotiorum, with control efficiency of up to 88.30%. This dry flowable formulation of C. rosea is a new potential commercial fungicide for spray drying to control S. sclerotiorum.
As a target of insect growth regulators, the
ecdysone receptor complex binds ecdysone agonists
to regulate gene transcription, development, and
growth. To understand the response of Lymantria dispar
to methoxyfenozide, we studied receptor complex
transcription profiles following larval exposure to
methoxyfenozide, and observed important variations
amongst post-embryonic stages. After the exposure of
2nd and 3rd instar larvae to LC5 and LC20 methoxyfenozide
for 72 h, the transcription levels of ecdysone receptor
complex genes were mainly upregulated in 2nd instar
larvae, but downregulated in 3rd instar larvae. These
results provide expression characteristics of the ecdysone
receptor complex in L. dispar larvae after methoxyfenozide
exposure.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.